University of Exeter
OrganisationROR
People
Principal Investigator
Principal Investigator
Principal Investigator
Professor
Principal Investigator
Lead applicant
Lead applicant
Lead investigator
Assistant professor (lecturer)
Lead investigator
Lead investigator
Lead investigator
Sources: gtr.ukri.org, reporter.nih.gov, grantnav.threesixtygiving.org, openalex.org
Trials
Collaborator, Phase 1, Completed, 16 people, 14 Jan 2025
Collaborator, Phase 1/2, Recruiting, 34 people, 19 Oct 2023
Phase 4, Withdrawn, 0 people, 29 Aug 2016
Collaborator, Phase 4, Completed, 525 people, 12 Jan 2016
Collaborator, Phase 4, Status unknown, 30 people, 8 Dec 2015
Collaborator, Phase 4, Completed, 90 people, 8 Dec 2015
Grants and prizes
Natural Environment Research Council
Research Grant, The Evolutionary Ecology of Social Ageing, UKRI2652, £793.7k, 2026–2029, 1 Apr 2026
National Institute for Health and Care Research
Public Health Research, SHIFTS-UPF: Study on Health Impacts of Food Taxes and Subsidies affecting Ultra Processed Food, NIHR174753, £818.1k, 2026–2028, 1 Feb 2026
UKRI | Medical Research Council
Research Grant, Assessing the usability and feasibility of a novel bone-specific activity-tracking app to help prevent osteoporosis in the real world at scale, UKRI3263, £196.5k, 2026–2027, 5 Jan 2026
UKRI | Medical Research Council
Research Grant, Genetic and Environmental Modifiers of Haemochromatosis Clinical Penetrance (GEM-H), UKRI2536, £1m, 2025–2028, 1 Dec 2025
R01, Social Modifiers of Primate Lifespan, R01AG087902, US$624.4k, 2024–2030, 18 Aug 2025
UKRI | Medical Research Council
Fellowship, Deciphering the Non-Coding Genome using Millions of Diverse Whole-Genome Sequences, UKRI327, £1.1m, 2025–2030, 1 Apr 2025
Wellcome Accelerator Awards, Investigating the risk of harm to Black men in prostate cancer diagnosis, 314362/Z/24/Z, £233.9k, 2025–2027, 30 Nov 2024
National Institute for Health and Care Research
Global Health Research Units and Groups, Improving outcomes for people with type 2 diabetes in Sub-Saharan Africa, NIHR156184, £3m, 2024–2028, 1 Jul 2024
Discovery Award, The Healthy Reproductive Ageing (HERA) Study, 302536/Z/23/Z, £3.8m, 2024–2030, 25 Jan 2024
PhD Studentship, Brain penetration of metformin: friend or foe in diabetes?, 22/0006486, £106.1k, 2023–2026, 1 Oct 2023
National Institute for Health and Care Research
Invention for Innovation, Clinical validation and commercialisation of the ReaCTIVE app: A proactive, interactive cognitive monitoring and intervention solution for people with early cognitive impairment, NIHR204284, £1.9m, 2023–2028, 1 Sept 2023
R01, A multi-omic approach to elucidate novel disease mechanisms and biomarkers for psychosis in Alzheimer’s disease, R01AG067015, US$275.2k, 2019–2024, 9 Jun 2023
National Institute for Health and Care Research
NIHR Fellowships, Understanding the causes and clinical implications of blood pressure decline in older age, NIHR302270, £1.1m, 2022–2028, 1 Sept 2022
European Foundation for the Study of Diabetes
EFSD Rising Star Fellowship Programme supported by Novo Nordisk, Individual-level cardiovascular and heart failure risk stratification to inform precision SGLT2-inhibitor treatment, EFSD-nn-rising-star-2022-john-dennis, 2022, 1 Jan 2022
National Institute for Health and Care Research
NIHR Fellowships, Enabling timely diagnosis of hereditary haemochromatosis, NIHR301844, £315k, 2021–2025, 1 Nov 2021
Alzheimer's Drug Discovery Foundation
Clinical, A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer’s Disease, Nested within a Multi-Arm Phase 2 Clinical Trial Platform, ADDF-21208491, US$3.2m, 2021–2027, 1 Apr 2021
National Institute for Health and Care Research
Health Technology Assessment, Effectiveness and cost-effectiveness of gynaecological surveillance for women with Lynch syndrome: systematic reviews and economic evaluation, NIHR129713, £308.5k, 2020–2022, 1 Sept 2020
National Institute for Health and Care Research
Efficacy and Mechanism Evaluation, Developing a working platform for a treatment selection algorithm for glucose lowering in Type 2 diabetes, NIHR129108, £49.9k, 2019–2020, 1 Jun 2019
Defining the role of mitochondrial hydrogen sulfide in healthspan extension in c, W911NF1910235, US$448k, 2019–2023, 25 Mar 2019
Project Grant, The vascular actions of glucagon-like peptide-1 analogues and its mediators in people with type 2 diabetes and diabetic retinopathy, 16/0005489, £200k, 2017–2020, 2 Jan 2017
Sources: gtr.ukri.org, fundingawards.nihr.ac.uk, reporter.nih.gov, grantnav.threesixtygiving.org, openalex.org, usaspending.gov
Named in competing interests
Employment, 1 Aug 2026
Sources: pubmed.ncbi.nlm.nih.gov